Search results
In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. [3] Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.
View Heather Manchin’s profile on LinkedIn, a professional community of 1 billion members. I recently transitioned from CEO of Mylan to being a Champion of Change for healthcare…
In May, Heather Bresch, CEO of the generic producer Mylan, projected annual sales as high as $11.5 billion, quite a jump from 2012's $6.1 billion, her first year.
29 lip 2019 · During Mylan CEO Heather Bresch's 28-year stint there, the company has utterly transformed into a generics giant—and courted controversy along the way.
6 gru 2017 · Heather Bresch. CEO, Mylan NV. CEO of Mylan, a global pharmaceutical company that specializes in prescription generic and brand-name medicines, and over-the-counter (OTC) offerings. Most Popular Health and Healthcare Systems. The future of global health and healthcare: game-changers for impact. CEO of the American Health Association ...
7 wrz 2021 · Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new...
Heather Bresch, the chief executive of Mylan, which raised the price of EpiPens, is the daughter of Senator Joe Manchin III of West Virginia. By Emmarie Huetteman
